167 related articles for article (PubMed ID: 25766447)
1. Eccrine squamous syringometaplasia of underlying syringoma associated with Tegafur/Gimeracil/Oteracil (TS-1).
Kim J; Kim SH; Lee MG; Chung KY; Kim DS
Acta Derm Venereol; 2015 Nov; 95(8):999-1000. PubMed ID: 25766447
[No Abstract] [Full Text] [Related]
2. Eccrine squamous syringometaplasia associated with vemurafenib therapy.
Story SG; Beschloss JK; Dolan CK; Thomas BC
J Am Acad Dermatol; 2012 Nov; 67(5):e208-10. PubMed ID: 23062917
[No Abstract] [Full Text] [Related]
3. Eccrine squamous syringometaplasia secondary to pegylated liposomal doxorubicin.
Garcia-Navarro X; Puig L; Fernández-Figueras MT; Alomar A
Arch Dermatol; 2008 Oct; 144(10):1402-3. PubMed ID: 18936417
[No Abstract] [Full Text] [Related]
4. [Tegafur/gimeracil/oteracil (Teysuno), by oral administration].
Duh D; Warnez M
J Pharm Belg; 2013 Dec; (4):35-6. PubMed ID: 24449972
[No Abstract] [Full Text] [Related]
5. Effectiveness and safety of tegafur-gimeracil-oteracil potassium (TS-1) for metastatic breast cancer: a single-center retrospective study.
Ishizuna K; Ninomiya J; Ogawa T; Kojima M; Tsuji E; Kawashima M; Nozaki M; Yamagishi H; Ueda Y
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2577-82. PubMed ID: 25596051
[TBL] [Abstract][Full Text] [Related]
6. Eccrine squamous syringometaplasia mimicking a herpetic infection.
Alonso V; Ramón D; Monteagudo C; Llombart B; Martín JM; García L; Jordá E
Int J Dermatol; 2006 Jun; 45(6):762-3. PubMed ID: 16796646
[No Abstract] [Full Text] [Related]
7. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
Park YJ; Soh BW; Lee ES
Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899
[No Abstract] [Full Text] [Related]
8. Vincristine-induced eccrine squamous syringometaplasia.
Thomas LM; Mohr M; Smith M; Boyd A
Pediatr Dermatol; 2008; 25(6):623-5. PubMed ID: 19067868
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
Wang HF; Lv JQ
Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
[TBL] [Abstract][Full Text] [Related]
10. Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
Matsuda K; Namiki T; Ueno M; Hashimoto T; Hanafusa T; Yokozeki H
Eur J Dermatol; 2017 Jun; 27(3):323-325. PubMed ID: 28414195
[No Abstract] [Full Text] [Related]
11. [TS-1 therapy for advanced gastric cancer].
Kurihara M; Koizumi W; Hasegawa K; Sakata Y; Ohtsu A; Taguchi T
Nihon Rinsho; 2001 Apr; 59 Suppl 4():393-7. PubMed ID: 11424413
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
Wang T; Zhang SF; Qiu MQ; Li QL
Cancer Radiother; 2016 May; 20(3):181-6. PubMed ID: 27068497
[TBL] [Abstract][Full Text] [Related]
13. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
14. [Eccrine squamous syringometaplasia and cytomegalovirus infection].
Baysse L; Boralevi F; Lepreux S; Boyer A; Morel C; Léauté-Labrèze C; Taïeb A
Rev Med Interne; 2003 Jun; 24(6):394-8. PubMed ID: 12814829
[TBL] [Abstract][Full Text] [Related]
15. Ex Vivo Fluorescence Confocal Microscopy of Eccrine Syringomatous Carcinoma: A Report of 2 Cases.
Longo C; Ragazzi M; Gardini S; Moscarella E; Argenziano G
JAMA Dermatol; 2015 Sep; 151(9):1034-6. PubMed ID: 26017696
[No Abstract] [Full Text] [Related]
16. Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.
Prescrire Int; 2013 May; 22(138):122. PubMed ID: 23819172
[TBL] [Abstract][Full Text] [Related]
17. Syringoid eccrine carcinoma.
Abedi SM; Yu R; Salama S; Alowami S
Cutis; 2015 Sep; 96(3):162,191-2. PubMed ID: 26562272
[No Abstract] [Full Text] [Related]
18. Syringoma-like eccrine sweat duct proliferation induced by radiation.
Yoshii N; Kanekura T; Churei H; Kanzaki T
J Dermatol; 2006 Jan; 33(1):36-9. PubMed ID: 16469082
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.
Komatsu-Fujii T; Ogawa M; Nonoyama S; Fukumoto T; Tanabe H
Eur J Dermatol; 2021 Feb; 31(1):98-99. PubMed ID: 33586655
[No Abstract] [Full Text] [Related]
20. [Eccrine syringofibroadenoma. Report of a case].
Grimaud H; Le Gall F; Adamski H; Wechsler J; Chevrant-Breton J
Ann Pathol; 1997 Mar; 17(1):52-4. PubMed ID: 9162160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
